Insights, updates, and expert knowledge on cannabis cultivation, compliance, and industry trends.
A practical guide for international cannabis importers on structuring a B2B supply agreement with a Canadian Licensed Producer: core clauses, Health Canada export compliance, market-specific regulatory addenda for Germany, Australia, and Israel, and offtake structures.
Five contract clauses every B2B cannabis buyer should negotiate before signing a supply agreement with a Canadian Licensed Producer.
A step-by-step guide to Israel's IMCA cannabis import permit process for Canadian LPs, covering IMC-GMP alignment, the 7-document qualification package, and first-shipment timelines.
A complete guide for Canadian Licensed Producers on exporting cannabis to Australia in 2026, covering TGA access pathways, ODC import permits, TGO 93 quality specifications, and Health Canada export permit requirements.
Brazil's medical cannabis import channel is growing, and Canadian Licensed Producers are well positioned to supply it. This guide covers ANVISA's import framework, the Health Canada export permit process, GMP documentation requirements, and realistic supply chain timelines for 2026.
A cannabis B2B supply agreement decides who absorbs a rejected batch, who carries currency risk, and what happens when a permit lapses. This guide covers the quality, pricing, regulatory, and termination terms procurement and business development teams should negotiate with a Canadian LP.
A single COA is a snapshot; stability testing shows how a batch holds up through transit and storage. What B2B buyers should ask a Canadian LP to provide.
A practical compliance guide for Canadian LPs entering the Australian medical cannabis market in 2026, covering TGA and ODC requirements, TGO 93 product standards, and the five-step export path.
Cannabis contaminant testing limits are not a single fixed table. This B2B guide explains the four COA contaminant panels, how Health Canada ties limits to pharmacopoeial standards and route of use, where EU buyers raise the bar, and a four-point checklist for verifying an incoming batch.
There is no single EU cannabis import framework. This guide compares the four most relevant EU medical cannabis markets for a Canadian LP in 2026, with the regulator, quality standard, and entry friction for each, plus a sequenced market-entry path.
A GPP audit checks whether your quality systems work in practice. How Canadian LPs stay audit-ready year-round and why it protects export continuity.
A practical guide for Canadian Licensed Producers on IMCA supplier approval, IMC-GAP and IMC-GMP compliance, the Israel import permit process, and what Israeli pharmaceutical distributors evaluate in a Canadian cannabis supply partner.